FOLD |
AMICUS THERAPEUTICS, INC. |
Jun 6, 2024 |
2 |
$0 |
4 |
Jun 7, 2024 |
Director |
NBIX |
NEUROCRINE BIOSCIENCES INC |
Feb 13, 2024 |
3 |
-$148K |
4 |
Feb 15, 2024 |
Chief Medical Officer |
NBIX |
NEUROCRINE BIOSCIENCES INC |
Feb 6, 2024 |
2 |
-$291K |
4 |
Feb 8, 2024 |
Chief Medical Officer |
NBIX |
NEUROCRINE BIOSCIENCES INC |
Jan 31, 2024 |
1 |
-$205K |
4 |
Feb 2, 2024 |
Chief Medical Officer |
NBIX |
NEUROCRINE BIOSCIENCES INC |
Dec 22, 2023 |
1 |
-$1.27M |
4 |
Dec 27, 2023 |
Chief Medical Officer |
NBIX |
NEUROCRINE BIOSCIENCES INC |
Dec 12, 2023 |
6 |
-$1.68M |
4 |
Dec 14, 2023 |
Chief Medical Officer |
NBIX |
NEUROCRINE BIOSCIENCES INC |
Dec 7, 2023 |
18 |
-$9.35M |
4 |
Dec 11, 2023 |
Chief Medical Officer |
NBIX |
NEUROCRINE BIOSCIENCES INC |
Dec 6, 2023 |
3 |
-$1.01M |
4 |
Dec 8, 2023 |
Chief Medical Officer |
NBIX |
NEUROCRINE BIOSCIENCES INC |
Aug 21, 2023 |
1 |
-$343K |
4 |
Aug 23, 2023 |
Chief Medical Officer |
FOLD |
AMICUS THERAPEUTICS, INC. |
Jun 8, 2023 |
2 |
$0 |
4 |
Jun 12, 2023 |
Director |
NBIX |
NEUROCRINE BIOSCIENCES INC |
Apr 24, 2023 |
1 |
-$1.49M |
4 |
Apr 26, 2023 |
Chief Medical Officer |
NBIX |
NEUROCRINE BIOSCIENCES INC |
Feb 13, 2023 |
2 |
$0 |
4 |
Feb 15, 2023 |
Chief Medical Officer |
NBIX |
NEUROCRINE BIOSCIENCES INC |
Feb 6, 2023 |
4 |
-$1.7M |
4 |
Feb 8, 2023 |
Chief Medical Officer |
NBIX |
NEUROCRINE BIOSCIENCES INC |
Jan 31, 2023 |
1 |
-$160K |
4 |
Feb 2, 2023 |
Chief Medical Officer |
FOLD |
AMICUS THERAPEUTICS, INC. |
Jun 9, 2022 |
2 |
$0 |
4 |
Jun 10, 2022 |
Director |
NBIX |
NEUROCRINE BIOSCIENCES INC |
Feb 7, 2022 |
3 |
-$300K |
4 |
Feb 9, 2022 |
Chief Medical Officer |
NBIX |
NEUROCRINE BIOSCIENCES INC |
Jan 31, 2022 |
2 |
$0 |
4 |
Feb 2, 2022 |
Chief Medical Officer |
NBIX |
NEUROCRINE BIOSCIENCES INC |
Jan 10, 2022 |
1 |
-$196K |
4 |
Jan 12, 2022 |
Chief Medical Officer |
FOLD |
AMICUS THERAPEUTICS, INC. |
Jun 10, 2021 |
2 |
$0 |
4 |
Jun 14, 2021 |
Director |
FOLD |
AMICUS THERAPEUTICS, INC. |
Jun 10, 2021 |
0 |
$0 |
3 |
Jun 14, 2021 |
Director |
NBIX |
NEUROCRINE BIOSCIENCES INC |
Nov 12, 2020 |
0 |
$0 |
4/A |
Apr 26, 2023 |
Chief Medical Officer |